Michelle Yanez - Aug 27, 2024 Form 4 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Chief Financial Officer
Signature
/s/ Michelle Yanez
Stock symbol
TELO
Transactions as of
Aug 27, 2024
Transactions value $
$0
Form type
4
Date filed
9/4/2024, 01:37 PM
Previous filing
Aug 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELO Incentive Stock Options (right to buy) Award $0 +200K $0.00 200K Aug 27, 2024 Common Stock 200K $5.02 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.
F2 The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50,000 stock options of such grant shall vest, respectively, on each of February 26, 2025, August 26, 2025, February 26, 2026 and August 26, 2026.